U.S. Gas Utilities Stock News

NYSE:WM
NYSE:WMCommercial Services

Is Waste Management (WM) Fairly Priced After Recent Share Price Weakness?

Wondering whether Waste Management's current share price reflects its true value, or if you might be paying too much for a steady, essential service stock. The stock recently closed at US$220.52, with returns of a 4.3% decline over 7 days, a 5.7% decline over 30 days, a 1.0% gain year to date, and a 4.9% decline over the past year. The 3 year and 5 year returns stand at 35.4% and 72.5% respectively. Recent coverage has focused on Waste Management's position as a core provider in the...
NYSE:RTX
NYSE:RTXAerospace & Defense

RTX Engine And Radar Wins Spark Fresh Look At Valuation And Growth

Pratt & Whitney, part of NYSE:RTX, secured an order to power 150 Airbus A220 aircraft for AirAsia X with its GTF engines, alongside a 12 year maintenance agreement. Raytheon, also under RTX, won its largest contract so far for SharpSight radars, expanding deployment of the surveillance system across multiple international markets. Together, these wins point to growing demand for RTX technologies across both commercial aviation and defense customers. RTX, which last closed at $176.74, is...
NYSE:ITW
NYSE:ITWMachinery

A Look At Illinois Tool Works (ITW) Valuation As 2026 EPS Guidance Rises On Q1 Beat

Illinois Tool Works (ITW) raised its full year 2026 GAAP EPS guidance to a range of $11.10 to $11.50, alongside Q1 earnings that topped expectations and an outlook for higher operating margins. See our latest analysis for Illinois Tool Works. The raised 2026 guidance and Q1 beat come after a mixed stretch for the stock, with a 2.35% 1 day share price gain but a 9.63% 90 day share price decline, while 1 year total shareholder return of 11.15% points to steadier long term momentum. If you are...
NYSE:ABBV
NYSE:ABBVBiotechs

How Investors Are Reacting To AbbVie (ABBV) Leaning On Immunology After Q1 Profit Decline

In late April and early May 2026, AbbVie reported first‑quarter revenue of US$15.00 billion alongside a year-on-year drop in net income to US$695 million, while unveiling extensive new clinical and regulatory updates for immunology drugs SKYRIZI and RINVOQ in inflammatory bowel disease, rheumatoid arthritis and alopecia areata. Together with fresh Canadian formulary listings for SKYRIZI in ulcerative colitis and new real‑world data showing lower switch rates and healthcare utilization in...
NYSE:ALK
NYSE:ALKAirlines

Alaska Air Group (ALK) Valuation Check As New Bond Issue Reshapes Funding And Growth Expectations

Why Alaska Air Group Just Tapped the Bond Market Alaska Air Group (ALK) has launched a US$500 million senior unsecured notes offering due 2031, a move that puts its balance sheet decisions and funding mix in clearer focus for stock and bond investors. See our latest analysis for Alaska Air Group. The bond announcement came alongside a short term rebound in the stock, with a 1 day share price return of 5.19% and a 7 day gain of 5.74%. However, the 1 year total shareholder return of 19.24% and...
NYSE:DV
NYSE:DVMedia

What DoubleVerify Holdings (DV)'s Stronger Q1 Profitability Means For Shareholders

DoubleVerify Holdings, Inc. recently reported first-quarter 2026 results, posting sales of US$180.83 million and net income of US$6.41 million, with diluted earnings per share from continuing operations of US$0.04, all higher than the same period a year earlier. The combination of higher revenue and improved profitability in the quarter highlights the company’s increasing operational efficiency and ability to convert growth into earnings. We’ll now examine how this improved quarterly...
NasdaqGS:CME
NasdaqGS:CMECapital Markets

A Look At CME Group (CME) Valuation After Bitcoin Volatility Futures Launch News

CME Group (CME) has put cryptocurrency derivatives back in focus after announcing plans to launch Bitcoin Volatility futures on June 1, alongside reporting April average daily volume of 25.9 million contracts. See our latest analysis for CME Group. The stock has cooled off recently, with a 6.6% decline in the 1 month share price return and a 3% dip over 3 months. Even so, the year to date share price return is 6.9% and the 5 year total shareholder return sits at 66%, suggesting longer term...
NYSE:UPS
NYSE:UPSLogistics

Is It Time To Reassess United Parcel Service (UPS) After Recent Share Price Weakness?

If you are wondering whether United Parcel Service stock offers solid value at around US$99.89, it helps to step back from the headlines and look carefully at what the current price may already be pricing in. Over the last week the stock is down 6.3%, while the 1 year return sits at 13.6%. This contrasts with weaker returns of a 1.1% decline year to date, a 31.8% decline over 3 years and a 41.3% decline over 5 years. Recent coverage has focused on how parcel volumes, cost efficiency...
NasdaqGS:IART
NasdaqGS:IARTMedical Equipment

Integra LifeSciences (IART) Balances Recall Challenges And Reaffirmed 2026 Guidance Is Management’s Credibility Shifting?

Integra LifeSciences Holdings has already implemented a leadership shake-up, with long-time chairman Stuart M. Essig returning as president and chief executive officer and Michael McBreen named chief commercial officer, alongside first-quarter 2026 results showing higher sales of US$391.92 million and a narrower net loss of US$4.62 million. These changes come as the company manages multiple ongoing Class II recalls of its Cytal burn and wound matrix devices due to elevated endotoxin levels,...
NYSE:MUX
NYSE:MUXMetals and Mining

McEwen Expands Nevada Footprint With Golden Lake Deal Near Gold Bar

McEwen (NYSE:MUX) has completed the acquisition of Golden Lake Resources. The deal adds ground adjacent to the Gold Bar Mine Complex in Nevada to McEwen's resource base. This transaction is focused on expanding McEwen's future resource potential around an existing producing hub. For investors watching NYSE:MUX, this move extends McEwen's footprint in Nevada, a key jurisdiction for its gold operations. By bringing Golden Lake Resources into the fold next to the Gold Bar Mine Complex, the...
NasdaqCM:NEXT
NasdaqCM:NEXTOil and Gas

Did NEXT’s On‑Track Rio Grande LNG Project Offset Its Widening Losses Just Shift NextDecade’s (NEXT) Investment Narrative?

NextDecade Corporation recently reported that for the quarter ended March 31, 2026, its net loss widened to US$136.41 million, or US$0.51 per basic share from continuing operations, compared with a US$88.81 million loss and US$0.34 per share a year earlier. At the same time, the company reported that construction of its Rio Grande LNG facility remains on budget and ahead of schedule, with early electrical commissioning underway and strong interest in future liquefaction trains amid tighter...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings Market Making Update Adds New Angle To Engagement And Value

DraftKings (NasdaqGS:DKNG) is integrating market-making capabilities into its Predictions platform, expanding how users can interact with contests and pricing. The update is positioned as a product shift aimed at deepening engagement and supporting more targeted marketing efforts. Industry watchers view this as a differentiator in digital sports entertainment and gaming rather than a routine feature tweak. For you as an investor, this development sits at the crossroads of sports betting,...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast Rural Broadband Push And What It Could Mean For Investors

Comcast (NasdaqGS:CMCSA) has expanded broadband service to previously unserved homes and businesses in rural Florida and Indiana. The company recently connected hundreds of new locations in Nassau County, Florida, through public private partnerships and infrastructure investments. Comcast also brought broadband to more than 2,100 premises in Central Indiana as part of its broader rural build out. For investors tracking Comcast, this rural expansion adds another dimension to the core cable,...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

Star Bulk Carriers (SBLK) Is Up 8.1% After Earnings Upgrades and Q1 2026 Results Date Set

Star Bulk Carriers Corp. has scheduled the release of its first-quarter 2026 financial results for after the U.S. market close on 20 May 2026, followed by a management conference call and webcast on 21 May 2026 at 11:00 a.m. Eastern Time. Beyond the routine earnings timetable, the company has drawn increased attention due to strong upward revisions in earnings estimates and an upgrade to a top-tier analyst ranking ahead of the results. We’ll now look at how this wave of earnings estimate...
NYSE:STVN
NYSE:STVNLife Sciences

Is Stevanato Group (STVN) Still Attractive After A 38% Monthly Share Price Surge?

Wondering whether Stevanato Group at around US$19 still offers value, or if the recent enthusiasm has already been priced in? This article focuses squarely on what that price tag may imply. The stock has had a sharp move recently, with a 16.9% return over the past week and 37.8% over the past month, even though it still shows a 7.7% decline year to date and a 12.6% decline over the last year. Recent coverage has focused on Stevanato Group as part of broader market conversations around life...
NYSE:AGX
NYSE:AGXConstruction

Argan (AGX) Valuation Check After Powerful Share Price Momentum And Strong Revenue Growth

Argan stock performance and business snapshot Argan (AGX) has drawn attention after a very large total return over the past year, together with returns over the past month and past 3 months that stand out versus shorter timeframes. For readers looking at the business behind the stock, Argan reports revenue of US$944.606m and net income of US$137.774m, with annual revenue growth of 18.03% and net income growth of 17.26%. See our latest analysis for Argan. The recent move in Argan’s share...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Angelini Pharma’s $3.9b Cash Deal Caps Catalyst Pharmaceuticals Upside Risks

On May 7, 2026, Angelini Pharma agreed to acquire Catalyst Pharmaceuticals for $3.9b in cash. The deal moves NasdaqCM:CPRX from takeover speculation to a definitive acquisition agreement. The transaction is subject to shareholder and regulatory approvals before closing. Catalyst Pharmaceuticals, trading on NasdaqCM:CPRX, is now at the center of a $3.9b all cash takeover agreement that sets a clear reference point for the stock. With a last close of $30.52 and a value score of 4, the company...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials (SOLS) Is Up 6.6% After Mixed Q1 Earnings and Dividend Reaffirmation - What's Changed

Solstice Advanced Materials reported first-quarter 2026 results with net sales rising to US$991 million from US$897 million a year earlier, while net income declined to US$85 million from US$134 million, and the board affirmed a quarterly dividend of US$0.075 per share payable on June 10, 2026. The results highlight how Solstice’s role across AI cooling, nuclear fuel conversion, and semiconductor materials is becoming increasingly central even as reported earnings lag top-line...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods Faces Rising Scrutiny On Chinese Ties And Farmland Risk

U.S. authorities are increasing scrutiny of Smithfield Foods' foreign ownership ties, focusing on its Chinese parent and U.S. farmland holdings. National security reviews are expanding to foreign-owned agricultural land, especially near sensitive sites, putting Smithfield Foods' property footprint under closer review. These developments introduce fresh policy and perception risks for Smithfield Foods, which have not been reflected in earlier coverage. For investors tracking NasdaqGS:SFD,...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Is ACADIA Pharmaceuticals (ACAD) Offering Value After A 45% One Year Share Price Gain?

If you are trying to work out whether ACADIA Pharmaceuticals at around US$21.48 is attractively priced or not, the key question is what you are really getting for that price. The stock is currently around 18.3% lower year to date, yet it has returned 45.0% over the last year, a mix that can change how the market is thinking about both potential and risk. Recent news flow around ACADIA Pharmaceuticals has largely focused on its position in the pharmaceuticals and biotech space and how...
NYSE:TALO
NYSE:TALOOil and Gas

Talos Energy (TALO) Q1 Loss Of US$256 Million Reinforces Bearish Profitability Narratives

Talos Energy (TALO) opened 2026 with Q1 revenue of US$472.3 million and a basic EPS loss of US$1.52, alongside trailing 12 month revenue of US$1.7 billion and a TTM basic EPS loss of US$4.30. This keeps the story centered on loss-making operations rather than profit growth. Over recent quarters the company has seen quarterly revenue move between US$392.2 million and US$512.9 million while EPS stayed in negative territory, reinforcing that investors are still watching for a turn in the...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Alphabet (NasdaqGS:GOOGL) Valuation In Focus After Strong Recent Share Price Momentum

Alphabet’s recent performance in focus Alphabet (GOOGL) has drawn fresh attention after recent share moves, with the stock showing a 2.5% gain over the past day and a 3.4% move over the past week. This has prompted closer scrutiny of fundamentals. See our latest analysis for Alphabet. Those short term moves sit on top of a much stronger backdrop, with a 30.3% 1 month share price return and a very large 1 year total shareholder return that points to strong momentum rather than a recent...
NYSE:FLOC
NYSE:FLOCEnergy Services

Flowco Holdings (FLOC) Margin Compression In Q1 2026 Tests Bullish Growth Narratives

Flowco Holdings (FLOC) has opened 2026 with Q1 revenue of US$209.5 million and basic EPS of US$0.24, setting the tone for how investors read the latest update against a changing profit profile. Over recent quarters the company has seen revenue move from US$192.4 million and EPS of US$0.24 in Q1 2025 to US$197.2 million and EPS of US$0.60 in Q4 2025, alongside trailing 12 month EPS of US$1.50 on revenue of US$776.9 million. As a result, the spotlight now sits squarely on whether margins can...
NYSE:MCK
NYSE:MCKHealthcare

McKesson’s New US$5b Credit Facility Reshapes Liquidity And Leverage Options

McKesson (NYSE:MCK) has entered into a new multi currency revolving credit agreement totaling US$5b. The facility replaces the company’s prior revolving credit arrangements and is scheduled to mature in April 2031. The agreement expands McKesson’s available committed liquidity and extends the duration of its bank credit support. McKesson is a major distributor of pharmaceuticals and medical supplies, so access to committed bank funding can be important when working with large inventories...